G. Salberg

First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases

S. Fosså, S. Nilsson, L. Balteskard, 2005, Clinical Cancer Research.

Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy

D. Olsen, Ø. Bruland, R. Larsen, 2006 .

First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases.

S. Fosså, S. Nilsson, L. Balteskard, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Liquid Scintillation Spectroscopy of 227Ac and Daughters

B. Schoultz, B. Ryningen, D. Eriksen, 2012 .

Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy.

D. Olsen, R. Larsen, O. Bruland, 2006, Nuclear medicine and biology.